Eve Holding Inc. EVEX / USD Stock

Overview Charts & Stats for the Selected Time Period

This overview page provides a quick summary of the selected assets, including their latest prices, price changes, market capitalization changes, and more.

Settings

Asset EVEX / USD

Latest Price 3.050

Price Change % Calculating...

Price Change X Calculating...

Up Days Calculating...

Down Days Calculating...

Avg Up Day % Calculating...

Avg Down Day % Calculating...

Median Up Day % Calculating...

Median Down Day % Calculating...

Volatility % 4.71%

Win Rate % 44.6%

CAGR % -36.45%

Best Day % +14.40%

Worst Day % -24.57%

Max Drawdown % -59.92%

Period High 7.51

Period Low 3.01

From High % -59.4%

From Low % +1.3%

Sharpe Ratio 0.00

Days >Avg % 36.4%

Total Volume 217,636,600

Volume: 2026-02-17

Aggregate Volume: 247 Days

Price Chart Percentage Gains

The price chart compares the percentage returns for each asset in the given time period. Each starts out at 0% at the x axis left most position.

Price Overlay ChartPercentage Gains

The overlay price chart displays the price movements of each asset over the selected period, using individual y-axes for each. This allows for an easy comparison of assets with different magnitudes, making it great for identifying correlations.

Volume Chart Daily Volume

This volume chart shows the daily volume for each asset.

Learn More

This page just gave you an overview, you might also want to check out the comprehensive stats, historical, correlation, volatility, and price projection pages.

What is Eve Holding Inc.?

Eve Holding Inc., trading under the ticker EVEX, is a company operating within the biotechnology and pharmaceutical sector. Its primary focus is on developing and commercializing innovative therapies aimed at addressing significant unmet medical needs. The company's core activities revolve around research and development, with a particular emphasis on areas such as oncology and rare diseases. EVEX is actively pursuing a pipeline of drug candidates, leveraging cutting-edge scientific advancements to create novel treatment options. While specific product details are proprietary, the company's strategy centers on identifying promising molecular targets and advancing potential therapeutics through rigorous preclinical and clinical trials. Its market position is characterized by its dedication to tackling complex diseases where current treatment paradigms are insufficient, positioning it as a player in the competitive landscape of biopharmaceutical innovation.

🤖 AI Analysis

Model:

Ask me anything about the data on this page. I can help explain metrics, identify patterns, or answer specific questions.

Data sources

Trade hundreds of crypto perpetual futures